Skip to main content
Premium Trial:

Request an Annual Quote

Paired Ends: Aug 24, 2010


San Francisco-based molecular diagnostics startup MLC Dx recently disclosed several company executives in an SEC filing.

Thomas Willis is the company’s president and CEO. Prior to that, he worked at Affymetrix, following the firm’s acquisition of ParAllele BioScience, a company he co-founded and where he served as CEO and later as CSO.

Malek Faham is the firm’s CSO. Previously, he was vice president of oncology technology research at Affymetrix, and before that, director of research at ParAllele, which he also co-founded.

Lawrence Tabak has been appointed as principal deputy director of the National Institutes of Health. He succeeds Raynard Kington, who is leaving the NIH to become president of Grinnell College in Iowa.

Tabak has served as director of the National Institute of Dental and Craniofacial Research since 2000. He also served as acting NIH deputy director in 2009 and, most recently, as acting director of the Division of Program Coordination, Planning, and Strategic Initiatives. Previously, he was a professor of dentistry, biochemistry, and biophysics at the School of Medicine and Dentistry at the University of Rochester. He holds a DDS from Columbia University, a PhD and a certificate of proficiency in endodontics from the University of Buffalo, and an undergraduate degree from City College of the City University of New York.

The Scan

Booster Push

New data shows a decline in SARS-CoV-2 vaccine efficacy over time, which the New York Times says Pfizer is using to argue its case for a booster, even as the lower efficacy remains high.

With Help from Mr. Fluffington, PurrhD

Cats could make good study animals for genetic research, the University of Missouri's Leslie Lyons tells the Atlantic.

Man Charged With Threatening to Harm Fauci, Collins

The Hill reports that Thomas Patrick Connally, Jr., was charged with making threats against federal officials.

Nature Papers Present Approach to Find Natural Products, Method to ID Cancer Driver Mutations, More

In Nature this week: combination of cryogenic electron microscopy with genome mining helps uncover natural products, driver mutations in cancer, and more.